Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Oncology
DOI: 10.1007/3-540-26420-5_1
|View full text |Cite
|
Sign up to set email alerts
|

An Introduction to Dynamic Contrast-Enhanced MRI in Oncology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
26
0

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 20 publications
(26 citation statements)
references
References 66 publications
0
26
0
Order By: Relevance
“…Contrast enhancement of breast lesions shows large physiologic variations, mostly depending on differences in vascular permeability (22,23) and other technical and physiological parameters, including type and dose of contrast material (24,25). Differences may depend on lesion histology, on the timing of imaging or on inhomogeneities within the lesions, such as those observed in necrotic areas or in fibrosis.…”
Section: Lesion Detectionmentioning
confidence: 99%
“…Contrast enhancement of breast lesions shows large physiologic variations, mostly depending on differences in vascular permeability (22,23) and other technical and physiological parameters, including type and dose of contrast material (24,25). Differences may depend on lesion histology, on the timing of imaging or on inhomogeneities within the lesions, such as those observed in necrotic areas or in fibrosis.…”
Section: Lesion Detectionmentioning
confidence: 99%
“…One is the shape of the curve and the other is how well the measured data fit the model curve. The shape of the curve is also conveyed by pharmacokinetic parameters (e.g., Kep Amp) (15)(16)(17), which can be color coded and overlaid on grayscale images, but the locally calculated values of the pharmacokinetic parameters may be irrelevant if the measured data do not fit the model curve well. Local GF information for the time-intensity curve is conveyed through auditory feedback while a reader draws a ROI.…”
Section: Discussionmentioning
confidence: 99%
“…2e), pharmacokinetic parameters (Amp: amplitude, Kep: redistribution rate constant, Kel: elimination rate constant; Tleg: time log; Fig. 2f) (15)(16)(17), image-slice information (Fig. 2g), and adjustable sound parameters ( Fig.…”
Section: Implementation Frameworkmentioning
confidence: 99%
“…In the early stage of cancer development, the tumor is nourished by diffusion of oxygen and nutrients provided by nearby blood vessels [2], [3]. In this phase, referred to as avascular phase, the tumor cannot grow beyond 1-2 mm in diameter [2], [3], [4].…”
Section: Introductionmentioning
confidence: 99%
“…In this phase, referred to as avascular phase, the tumor cannot grow beyond 1-2 mm in diameter [2], [3], [4]. The transition from a pre-vascular to a vascularized phase, known as "angiogenic switch", is required for the tumor to overcome this size limit.…”
Section: Introductionmentioning
confidence: 99%